“…The pharmacological treatment of DCC reported good results for some patients with subcutaneous and muscular involvement if the CNS is not severely affected [41,42]. On the other hand, have been confirmed cases with DCC and chronic liver disease in which case even if the ELISA test was suggestive, the final diagnosis was obtained by CT scans of the brain [43], and have been reported cases with unilateral eye lesion [44], and even bilaterally [80], thyroid involvement [8,45] , pancreatic enzyme alterations [46] or without clinical or biochemical alterations of pancreatic function [47], spleen damage [47,47], cardiac [8,[48][49][50][51][52][53], even without associated DCC [52], lung [45,[53][54][55], joints [56] and muscles of the face and neck [44,48].…”